Literature DB >> 11859100

Hyperproliferative response of a monoclonal memory CD8 T cell population is characterized by an increased frequency of clonogenic precursors.

Christophe Arpin1, Georgi Angelov, Thierry Walzer, Martine Tomkowiak, Laurent Beloeil, Jacqueline Marvel.   

Abstract

Strong memory T cell responses result partly from the selection of Ag-specific clones during immunization. In this study, we show that a monoclonal CD8 T cell population expressing a unique TCR is heterogeneous in terms of clonogenic potential following activation under optimal conditions. More importantly, the frequency of clonogenic cells is strongly increased among Ag-experienced cells, indicating that these cells were either generated or selected during the in vivo primary response. Moreover, strong proliferative responses of primed cells result from this enhanced frequency, as proliferating naive and primed cells display the same cycling parameters, i.e., lag time and intermitotic interval. Hence, these results suggest that the clonogenic potential of individual cells is imprinted before Ag encounter and that clonogenic precursors are selected or generated following in vivo activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11859100     DOI: 10.4049/jimmunol.168.5.2147

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Mathematical model of the primary CD8 T cell immune response: stability analysis of a nonlinear age-structured system.

Authors:  Emmanuelle Terry; Jacqueline Marvel; Christophe Arpin; Olivier Gandrillon; Fabien Crauste
Journal:  J Math Biol       Date:  2011-08-13       Impact factor: 2.259

2.  T inflammatory memory CD8 T cells participate to antiviral response and generate secondary memory cells with an advantage in XCL1 production.

Authors:  Virginie Jubin; Erwan Ventre; Yann Leverrier; Sophia Djebali; Katia Mayol; Martine Tomkowiak; Julien Mafille; Marie Teixeira; Denise Y-L Teoh; Bruno Lina; Thierry Walzer; Christophe Arpin; Jacqueline Marvel
Journal:  Immunol Res       Date:  2012-06       Impact factor: 4.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.